Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue-A Case Report and Brief Literature Review.

Claudine Desruisseaux, Michaël Bensoussan, Etienne Désilets, Hanh-Khiem Tran, Robert Arcand, Germain Poirier, Andrew Wisniewski, Thibaut Manière

Journal: Canadian journal of gastroenterology & hepatology 2017;2016():4837270

PMID: 27446843

Abstract

Collagenous sprue (CS) is a distinct clinicopathological disorder histologically defined by a thickened subepithelial band (Freeman, 2011). It is a rare condition which has been recently observed in a significant proportion of sprue-like enteropathy associated with olmesartan, a novel entity described by Rubio-Tapia et al. in 2012. CS is historically associated with a poor prognosis (Marthey et al., 2014). However, histological and clinical improvements have been described in most studies with concomitant usage of corticosteroids and/or gluten-free diet (Marthey et al., 2014). We report a unique case of olmesartan-induced collagenous sprue in a 79-year-old man that showed complete histological and clinical remission with the sole withdrawal of the incriminating drug. The literature on this topic is briefly reviewed.

Address: Gastroenterology Service, Charles-LeMoyne Hospital, Sherbrooke University, Greenfield Park, QC, Canada J4V 2H1.; Pathology Department, Charles-LeMoyne Hospital, Sherbrooke University, Greenfield Park, QC, Canada J4V 2H1.; Intensive Care Unit, Charles-LeMoyne Hospital, Sherbrooke University, Greenfield Park, QC, Canada J4V 2H1.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.